Stock in Tylenol’s parent company rallies after Trump’s unproven claims
2 days ago
2
ARTICLE AD BOX
Tylenol's parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.